Abstract
Choroidal hemangioma, a benign vascular tumor, exists in two clinically distinct forms as either a circumscribed or a diffuse lesion and typically involves the posterior pole. Most patients present with decreased visual acuity secondary to subretinal fluid (SRF). In addition to exam, optical coherence tomography (OCT), ultrasonography, fluorescein (FA) and indocyanine green (ICGA) angiography, and magnetic resonance imaging (MRI) all play a role in the diagnosis of choroidal hemangioma. This chapter explores various approaches to therapy, both historical and current, used to treat this choroidal tumor and secondary exudative retinal detachment (ERD). Treatment modalities include laser photocoagulation, transpupillary thermotherapy, photodynamic therapy (PDT), intravitreal anti-VEGF or steroid injection, systemic beta-blockers, plaque brachytherapy, proton beam irradiation, external beam radiotherapy, and gamma knife irradiation. There are many considerations to treatment which include size of the tumor, presence or absence of exudative retinal detachment, prior treatment failures, patient’s ability to undergo surgery, and other comorbidities. Time between onset of symptoms and treatment has been shown to affect visual prognosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CCH:
-
Circumscribed choroidal hemangioma
- CME:
-
Cystoid macular edema
- CNV:
-
Choroidal neovascularization
- DCH:
-
Diffuse choroidal hemangioma
- ERD:
-
Exudative retinal detachment
- FA:
-
Fluorescein angiography
- ICG-A:
-
Indocyanine green angiography
- IVB:
-
Intravitreal bevacizumab
- IVT:
-
Intravitreal triamcinolone
- LSRT:
-
Lens-sparing radiotherapy
- MRI:
-
Magnetic resonance imaging
- NVD:
-
Neovascularization of the disc
- NVE:
-
Retinal neovascularization elsewhere
- OCT:
-
Optical coherence tomography
- OCT-A:
-
Optical coherence tomography angiography
- PDT:
-
Photodynamic therapy
- RPE:
-
Retinal pigment epithelium
- SRF:
-
Subretinal fluid
- SWS:
-
Sturge-Weber syndrome
- TTT:
-
Transpupillary thermotherapy
- VEGF:
-
Vascular endothelial growth factor
References
Witschel H, Font RL. Hemangioma of the choroid. A clinicopathologic study of 71 cases and a review of the literature. Surv Ophthalmol. 1976;20(6):415–31.
Mashayekhi A, Shields CL. Circumscribed choroidal hemangioma. Curr Opin Ophthalmol. 2003;14(3):142–9.
Shields CL, Honavar SG, Shields JA, Cater J, Demirci H. Circumscribed choroidal hemangioma: clinical manifestations and factors predictive of visual outcome in 200 consecutive cases. Ophthalmology. 2001;108(12):2237–48.
Koenraads Y, van Egmond-Ebbeling MB, de Boer JH, Imhof SM, Braun KP, Porro GL. Visual outcome in Sturge-Weber syndrome: a systematic review and Dutch multicentre cohort. Acta Ophthalmol. 2016;94(7):638–45. https://doi.org/10.1111/aos.13074.
Cheung D, Grey R, Rennie I. Circumscribed choroidal haemangioma in a patient with Sturge Weber syndrome. Eye (Lond). 2000;14(Pt 2):238–40. https://doi.org/10.1038/eye.2000.61.
Jarrett WH 2nd, Hagler WS, Larose JH, Shields JA. Clinical experience with presumed hemangioma of the choroid: radioactive phosphorus uptake studies as an aid in differential diagnosis. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1976;81(5):862–70.
Hsu CC, Yang CS, Peng CH, Lee FL, Lee SM. Combination photodynamic therapy and intravitreal bevacizumab used to treat circumscribed choroidal hemangioma. J Chin Med Assoc. 2011;74(10):473–7. https://doi.org/10.1016/j.jcma.2011.08.020.
Shields JA, Shields CL. Intraocular tumors: an atlas and textbook. 2nd ed. Baltimore: Lippincott Williams & Wilkins; 2008.
Leys AM, Silva R, Inhoffen W, Tatar O. Neovascular growth following photodynamic therapy for choroidal hemangioma and neovascular regression after intravitreous injection of triamcinolone. Retina. 2006;26(6):693–7. https://doi.org/10.1097/01.iae.0000236482.40056.fe.
Hua R, Zhao N, Hu Y, Zhang CM, Chen L. Circumscribed choroidal hemangioma associated with choroidal neovascularization in a HIV-infected case: photodynamic therapy and intravitreous ranibizumab. Photodiagn Photodyn Ther. 2014;11(3):441–3. https://doi.org/10.1016/j.pdpdt.2014.04.005.
Scott IU, Alexandrakis G, Cordahi GJ, Murray TG. Diffuse and circumscribed choroidal hemangiomas in a patient with Sturge-Weber syndrome. Arch Ophthalmol. 1999;117(3):406–7.
Shields CL, Atalay HT, Wuthisiri W, Levin AV, Lally SE, Shields JA. Sector iris hemangioma in association with diffuse choroidal hemangioma. J AAPOS. 2015;19(1):83–6. https://doi.org/10.1016/j.jaapos.2014.09.012.
Plateroti AM, Plateroti R, Mollo R, Librando A, Contestabile MT, Fenicia V. Sturge-weber syndrome associated with monolateral ocular melanocytosis, Iris mammillations, and diffuse choroidal haemangioma. Case Rep Ophthalmol. 2017;8(2):375–84. https://doi.org/10.1159/000477612.
Tanabe H, Sahashi K, Kitano T, Tomita Y, Saito AM, Hirose H. Effects of oral propranolol on circumscribed choroidal hemangioma: a pilot study. JAMA Ophthalmol. 2013;131(12):1617–22. https://doi.org/10.1001/jamaophthalmol.2013.5669.
Medlock RD, Augsburger JJ, Wilkinson CP, Cox MS Jr, Gamel JW, Nicholl J. Enlargement of circumscribed choroidal hemangiomas. Retina. 1991;11(4):385–8.
Kwon HJ, Kim M, Lee CS, Lee SC. Treatment of serous macular detachment associated with circumscribed choroidal hemangioma. Am J Ophthalmol. 2012;154(1):137–145.e131. https://doi.org/10.1016/j.ajo.2012.01.007.
Schalenbourg A, Piguet B, Zografos L. Indocyanine green angiographic findings in choroidal hemangiomas: a study of 75 cases. Ophthalmologica. 2000;214(4):246–52. https://doi.org/10.1159/000027499.
Norton EW, Gutman F. Fluorescein angiography and hemangiomas of the choroid. Arch Ophthalmol. 1967;78(2):121–5.
Anand R. Photodynamic therapy for diffuse choroidal hemangioma associated with Sturge Weber syndrome. Am J Ophthalmol. 2003;136(4):758–60.
Arevalo JF, Shields CL, Shields JA, Hykin PG, De Potter P. Circumscribed choroidal hemangioma: characteristic features with indocyanine green videoangiography. Ophthalmology. 2000;107(2):344–50.
Singh AD, Kaiser PK, Sears JE. Choroidal hemangioma. Ophthalmol Clin N Am. 2005;18(1):151–161, ix. https://doi.org/10.1016/j.ohc.2004.07.004.
Krema H, Yousef YA, Durairaj P, Santiago R. Failure of systemic propranolol therapy for choroidal hemangioma of Sturge-Weber syndrome: a report of 2 cases. JAMA Ophthalmol. 2013;131(5):681–3. https://doi.org/10.1001/jamaophthalmol.2013.2879.
Arevalo JF, Arias JD, Serrano MA. Oral propranolol for exudative retinal detachment in diffuse choroidal hemangioma. Arch Ophthalmol. 2011;129(10):1373–5. https://doi.org/10.1001/archophthalmol.2011.294.
Cennamo G, Romano MR, Breve MA, Velotti N, Reibaldi M, de Crecchio G, Cennamo G. Evaluation of choroidal tumors with optical coherence tomography: enhanced depth imaging and OCT-angiography features. Eye (Lond). 2017;31(6):906–15. https://doi.org/10.1038/eye.2017.14.
Torres VL, Brugnoni N, Kaiser PK, Singh AD. Optical coherence tomography enhanced depth imaging of choroidal tumors. Am J Ophthalmol. 2011;151(4):586–593.e582. https://doi.org/10.1016/j.ajo.2010.09.028.
Shields CL, Manalac J, Das C, Saktanasate J, Shields JA. Review of spectral domain enhanced depth imaging optical coherence tomography of tumors of the choroid. Indian J Ophthalmol. 2015;63(2):117–21. https://doi.org/10.4103/0301-4738.154377.
Stroszczynski C, Hosten N, Bornfeld N, Wiegel T, Schueler A, Foerster P, Lemke AJ, Hoffmann KT, Felix R. Choroidal hemangioma: MR findings and differentiation from uveal melanoma. Am J Neuroradiol. 1998;19(8):1441–7.
Peyster RG, Augsburger JJ, Shields JA, Hershey BL, Eagle R Jr, Haskin ME. Intraocular tumors: evaluation with MR imaging. Radiology. 1988;168(3):773–9. https://doi.org/10.1148/radiology.168.3.3406407.
Damento GM, Koeller KK, Salomao DR, Pulido JS. T2 fluid-attenuated inversion recovery imaging of uveal melanomas and other ocular pathology. Ocular Oncol Pathol. 2016;2(4):251–61. https://doi.org/10.1159/000447265.
Ramasubramanian A, Shields CL, Harmon SA, Shields JA. Autofluorescence of choroidal hemangioma in 34 consecutive eyes. Retina. 2010;30(1):16–22. https://doi.org/10.1097/IAE.0b013e3181bceedb.
Anand R, Augsburger JJ, Shields JA. Circumscribed choroidal hemangiomas. Arch Ophthalmol. 1989;107(9):1338–42.
Tsipursky MS, Golchet PR, Jampol LM. Photodynamic therapy of choroidal hemangioma in Sturge-Weber syndrome, with a review of treatments for diffuse and circumscribed choroidal hemangiomas. Surv Ophthalmol. 2011;56(1):68–85. https://doi.org/10.1016/j.survophthal.2010.08.002.
Karimi S, Nourinia R, Mashayekhi A. Circumscribed choroidal hemangioma. J Ophthalmic Vis Res. 2015;10(3):320–8. https://doi.org/10.4103/2008-322x.170353.
Yim JF, Sandinha T, Kerr JM, Ritchie D, Kemp EG. Treatment review of sight threatening circumscribed choroidal haemangioma. Int J Ophthalmol. 2010;3(2):168–71. https://doi.org/10.3980/j.issn.2222-3959.2010.02.18.
Cennamo G, Breve MA, Rossi C, Romano MR, de Crecchio G, Cennamo G. Transpupillary thermotherapy as a primary treatment for circumscribed choroidal haemangioma. Acta Ophthalmol. 2016;94(2):e167–9. https://doi.org/10.1111/aos.12810.
Gambrelle J, Kivela T, Grange JD. Sturge-Weber syndrome: decrease in intraocular pressure after transpupillary thermotherapy for diffuse choroidal haemangioma. Acta Ophthalmol. 2011;89(2):190–3. https://doi.org/10.1111/j.1755-3768.2009.01811.x.
Newman DK. Photodynamic therapy: current role in the treatment of chorioretinal conditions. Eye (Lond). 2016;30(2):202–10. https://doi.org/10.1038/eye.2015.251.
Schmidt-Erfurth UM, Michels S, Kusserow C, Jurklies B, Augustin AJ. Photodynamic therapy for symptomatic choroidal hemangioma: visual and anatomic results. Ophthalmology. 2002;109(12):2284–94.
Chan WM, Lim TH, Pece A, Silva R, Yoshimura N. Verteporfin PDT for non-standard indications—a review of current literature. Graefe’s Arch Clin Exp Ophthalmol. 2010;248(5):613–26. https://doi.org/10.1007/s00417-010-1307-z.
Pilotto E, Urban F, Parrozzani R, Midena E. Standard versus bolus photodynamic therapy in circumscribed choroidal hemangioma: functional outcomes. Eur J Ophthalmol. 2011;21(4):452–8. https://doi.org/10.5301/ejo.2011.6263.
Su ZA, Tang XJ, Zhang LX, Su XH. Comparison of outcomes between overlapping-spot and single-spot photodynamic therapy for circumscribed choroidal hemangioma. Int J Ophthalmol. 2014;7(1):66–70. https://doi.org/10.3980/j.issn.2222-3959.2014.01.12.
Blasi MA, Tiberti AC, Scupola A, Balestrazzi A, Colangelo E, Valente P, Balestrazzi E. Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes. Ophthalmology. 2010;117(8):1630–7. https://doi.org/10.1016/j.ophtha.2009.12.033.
Hu Y, Chen Y, Chen L. Half-dosage and bolus injection photodynamic therapy for symptomatic circumscribed choroidal hemangioma: a case report. Photodiagn Photodyn Ther. 2015;12(3):526–9. https://doi.org/10.1016/j.pdpdt.2015.05.005.
Subira O, Brosa H, Lorenzo-Parra D, Arias-Barquet L, Catala-Mora J, Cobos E, Garcia-Bru P, Rubio-Caso MJ, Caminal-Mitjana JM. Choroidal haemangioma and photodynamic therapy. Anatomical and functional response of patients with choroidal hemangioma treated with photodynamic therapy. Arch Soc Esp Oftalmol. 2017;92(6):257–64. https://doi.org/10.1016/j.oftal.2016.11.013.
Huang S, Fabian J, Murray T, Shi W. Symptomatic circumscribed choroidal hemangioma undergoing PDT: VA outcomes. Optom Vis Sci. 2009;86(3):286–9. https://doi.org/10.1097/OPX.0b013e318196a724.
Xiong Y, Zhang F. Photodynamic therapy for circumscribed choroidal hemangioma. Zhonghua Yan Ke Za Zhi. 2007;43(12):1085–8.
Guagnini AP, De Potter P, Levecq L. Photodynamic therapy of circumscribed choroidal hemangiomas. J Fr Ophtalmol. 2006;29(9):1013–7.
Landau IM, Steen B, Seregard S. Photodynamic therapy for circumscribed choroidal haemangioma. Acta Ophthalmol Scand. 2002;80(5):531–6.
Hussain RN, Jmor F, Damato B, Heimann H. Verteporfin photodynamic therapy for the treatment of choroidal haemangioma associated with Sturge-Weber syndrome. Photodiagn Photodyn Ther. 2016;15:143–6. https://doi.org/10.1016/j.pdpdt.2016.06.009.
Nugent R, Lee L, Kwan A. Photodynamic therapy for diffuse choroidal hemangioma in a child with Sturge-Weber syndrome. J AAPOS. 2015;19(2):181–3. https://doi.org/10.1016/j.jaapos.2014.10.032.
Poh KW, Wai YZ, Rahmat J, Shunmugam M, Alagaratnam J, Ramasamy S. Treatment of diffuse choroidal haemangioma using photodynamic therapy. Int J Ophthalmol. 2017;10(3):488–90. https://doi.org/10.18240/ijo.2017.03.26.
Huiskamp EA, Muskens RP, Ballast A, Hooymans JM. Diffuse choroidal haemangioma in Sturge-Weber syndrome treated with photodynamic therapy under general anaesthesia. Graefe’s Arch Clin Exp Ophthalmol. 2005;243(7):727–30. https://doi.org/10.1007/s00417-004-1102-9.
Cacciamani A, Scarinci F, Parravano M, Giorno P, Varano M. Choroidal thickness changes with photodynamic therapy for a diffuse choroidal hemangioma in Sturge-Weber syndrome. Int Ophthalmol. 2014;34(5):1131–5. https://doi.org/10.1007/s10792-014-9933-9.
Li KZ, Tan CS. Changes in choroidal thickness after photodynamic therapy for Sturge-Weber syndrome. Int Ophthalmol. 2015;35(5):615–6. https://doi.org/10.1007/s10792-015-0077-3.
Nagesha CK, Walinjkar JA, Khetan V. Choroidal neovascular membrane in a treated choroidal hemangioma. Indian J Ophthalmol. 2016;64(8):606–8. https://doi.org/10.4103/0301-4738.191512.
Mandal S, Naithani P, Venkatesh P, Garg S. Intravitreal bevacizumab (avastin) for circumscribed choroidal hemangioma. Indian J Ophthalmol. 2011;59(3):248–51. https://doi.org/10.4103/0301-4738.81051.
Sagong M, Lee J, Chang W. Application of intravitreal bevacizumab for circumscribed choroidal hemangioma. Korean J Ophthalmol: KJO. 2009;23(2):127–31. https://doi.org/10.3341/kjo.2009.23.2.127.
Anaya-Pava EJ, Saenz-Bocanegra CH, Flores-Trejo A, Castro-Santana NA. Diffuse choroidal hemangioma associated with exudative retinal detachment in a Sturge-Weber syndrome case: photodynamic therapy and intravitreous bevacizumab. Photodiagn Photodyn Ther. 2015;12(1):136–9. https://doi.org/10.1016/j.pdpdt.2014.12.002.
Chan LW, Hsieh YT. Photodynamic therapy for choroidal hemangioma unresponsive to ranibizumab. Optom Vis Sci. 2014;91(9):e226–9. https://doi.org/10.1097/opx.0000000000000349.
Querques G, Forte R, Querques L, Souied EH. Intravitreal ranibizumab for choroidal neovascularization associated with circumscribed choroidal haemangioma. Clin Exp Ophthalmol. 2011;39(9):916–8. https://doi.org/10.1111/j.1442-9071.2011.02580.x.
Bach A, Gold AS, Villegas VM, Wildner AC, Ehlies FJ, Murray TG. Spontaneous exudative retinal detachment in a patient with Sturge-Weber syndrome after taking arginine, a supplement for erectile dysfunction. Eye Vis. 2014;1:7. https://doi.org/10.1186/s40662-014-0007-x.
Paulus YM, Jain A, Moshfeghi DM. Resolution of persistent exudative retinal detachment in a case of Sturge-Weber syndrome with anti-VEGF administration. Ocul Immunol Inflamm. 2009;17(4):292–4. https://doi.org/10.1080/09273940902989357.
Sommers Smith SK, Smith DM. Beta blockade induces apoptosis in cultured capillary endothelial cells. In Vitro Cell Dev Biol Anim. 2002;38(5):298–304. https://doi.org/10.1290/1071-2690(2002)038<0298:bbiaic>2.0.co;2.
Giatromanolaki A, Arvanitidou V, Hatzimichael A, Simopoulos C, Sivridis E. The HIF-2alpha/VEGF pathway activation in cutaneous capillary haemangiomas. Pathology. 2005;37(2):149–51.
Sanz-Marco E, Gallego R, Diaz-Llopis M. Oral propranolol for circumscribed choroidal hemangioma. Case Rep Ophthalmol. 2011;2(1):84–90. https://doi.org/10.1159/000325142.
Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taieb A. Propranolol for severe hemangiomas of infancy. N Engl J Med. 2008;358(24):2649–51. https://doi.org/10.1056/NEJMc0708819.
Thapa R, Shields CL. Oral propranolol therapy for management of exudative retinal detachment from diffuse choroidal hemangioma in Sturge-Weber syndrome. Eur J Ophthalmol. 2013;23(6):922–4. https://doi.org/10.5301/ejo.5000322.
Bazin L, Gambrelle J. Combined treatment with photodynamic therapy and intravitreal dexamethasone implant (Ozurdex((R))) for circumscribed choroidal hemangioma. J Fr Ophtalmol. 2012;35(10):798–802. https://doi.org/10.1016/j.jfo.2012.06.015.
Quagliano F, Fontana L, Parente G, Tassinari G. Choroidal effusion after diode laser cyclophotocoagulation in Sturge-Weber syndrome. J AAPOS. 2008;12(5):526–7. https://doi.org/10.1016/j.jaapos.2008.03.014.
Lopez-Caballero C, Saornil MA, De Frutos J, Bianciotto C, Muinos Y, Almaraz A, Lopez-Lara F, Contreras I. High-dose iodine-125 episcleral brachytherapy for circumscribed choroidal haemangioma. Br J Ophthalmol. 2010;94(4):470–3. https://doi.org/10.1136/bjo.2009.160184.
Zografos L, Bercher L, Chamot L, Gailloud C, Raimondi S, Egger E. Cobalt-60 treatment of choroidal hemangiomas. Am J Ophthalmol. 1996;121(2):190–9.
Madreperla SA, Hungerford JL, Plowman PN, Laganowski HC, Gregory PT. Choroidal hemangiomas: visual and anatomic results of treatment by photocoagulation or radiation therapy. Ophthalmology. 1997;104(11):1773–8; discussion 1779.
Aizman A, Finger PT, Shabto U, Szechter A, Berson A. Palladium 103 (103Pd) plaque radiation therapy for circumscribed choroidal hemangioma with retinal detachment. Arch Ophthalmol. 2004;122(11):1652–6. https://doi.org/10.1001/archopht.122.11.1652.
Kubicka-Trzaska A, Karska-Basta I, Oleksy P, Romanowska-Dixon B. Management of diffuse choroidal hemangioma in Sturge-Weber syndrome with Ruthenium-106 plaque radiotherapy. Graefe’s Arch Clin Exp Ophthalmol. 2015;253(11):2015–9. https://doi.org/10.1007/s00417-015-3061-8.
Frau E, Rumen F, Noel G, Delacroix S, Habrand JL, Offret H. Low-dose proton beam therapy for circumscribed choroidal hemangiomas. Arch Ophthalmol. 2004;122(10):1471–5. https://doi.org/10.1001/archopht.122.10.1471.
Levy-Gabriel C, Rouic LL, Plancher C, Dendale R, Delacroix S, Asselain B, Habrand JL, Desjardins L. Long-term results of low-dose proton beam therapy for circumscribed choroidal hemangiomas. Retina. 2009;29(2):170–5. https://doi.org/10.1097/IAE.0b013e31818bccfb.
Chan RV, Yonekawa Y, Lane AM, Skondra D, Munzenrider JE, Collier JM, Gragoudas ES, Kim IK. Proton beam irradiation using a light-field technique for the treatment of choroidal hemangiomas. Ophthalmologica. 2010;224(4):209–16. https://doi.org/10.1159/000260226.
Schilling H, Sauerwein W, Lommatzsch A, Friedrichs W, Brylak S, Bornfeld N, Wessing A. Long-term results after low dose ocular irradiation for choroidal haemangiomas. Br J Ophthalmol. 1997;81(4):267–73.
Ritland JS, Eide N, Tausjo J. External beam irradiation therapy for choroidal haemangiomas. Visual and anatomical results after a dose of 20 to 25 Gy. Acta Ophthalmol Scand. 2001;79(2):184–6.
Kim YT, Kang SW, Lee JI. Gamma knife radiosurgery for choroidal hemangioma. Int J Radiat Oncol Biol Phys. 2011;81(5):1399–404. https://doi.org/10.1016/j.ijrobp.2010.08.016.
Song WK, Byeon SH, Kim SS, Kwon OW, Lee SC. Gamma knife radiosurgery for choroidal haemangiomas with extensive exudative retinal detachment. Br J Ophthalmol. 2009;93(6):836–7. https://doi.org/10.1136/bjo.2008.151316.
Boixadera A, Garcia-Arumi J, Martinez-Castillo V, Encinas JL, Elizalde J, Blanco-Mateos G, Caminal J, Capeans C, Armada F, Navea A, Olea JL. Prospective clinical trial evaluating the efficacy of photodynamic therapy for symptomatic circumscribed choroidal hemangioma. Ophthalmology. 2009;116(1):100–105.e101. https://doi.org/10.1016/j.ophtha.2008.08.029.
Jurklies B, Anastassiou G, Ortmans S, Schuler A, Schilling H, Schmidt-Erfurth U, Bornfeld N. Photodynamic therapy using verteporfin in circumscribed choroidal haemangioma. Br J Ophthalmol. 2003;87(1):84–9.
Michels S, Michels R, Simader C, Schmidt-Erfurth U. Verteporfin therapy for choroidal hemangioma: a long-term follow-up. Retina. 2005;25(6):697–703.
Verbraak FD, Schlingemann RO, Keunen JE, de Smet MD. Longstanding symptomatic choroidal hemangioma managed with limited PDT as initial or salvage therapy. Graefe’s Arch Clin Exp Ophthalmol. 2003;241(11):891–8. https://doi.org/10.1007/s00417-003-0765-y.
Singh AD, Kaiser PK, Sears JE, Gupta M, Rundle PA, Rennie IG. Photodynamic therapy of circumscribed choroidal haemangioma. Br J Ophthalmol. 2004;88(11):1414–8. https://doi.org/10.1136/bjo.2004.044396.
Porrini G, Giovannini A, Amato G, Ioni A, Pantanetti M. Photodynamic therapy of circumscribed choroidal hemangioma. Ophthalmology. 2003;110(4):674–80. https://doi.org/10.1016/s0161-6420(02)01968-1.
Dave T, Dave VP, Shah G, Pappuru RR. Diffuse choroidal hemangioma masquerading as central serous chorioretinopathy treated with oral propranolol. Retin Cases Brief Rep. 2016;10(1):11–4. https://doi.org/10.1097/icb.0000000000000165.
Kaushik S, Kaur S, Pandav SS, Gupta A. Intractable choroidal effusion with exudative retinal detachment in Sturge-Weber syndrome. JAMA Ophthalmol. 2014;132(9):1143–4. https://doi.org/10.1001/jamaophthalmol.2014.2464.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Aebi, B.E., Jusufbegovic, D. (2019). Management of Choroidal Hemangioma. In: Ramasubramanian, A. (eds) Ocular Oncology . Current Practices in Ophthalmology. Springer, Singapore. https://doi.org/10.1007/978-981-13-7538-5_8
Download citation
DOI: https://doi.org/10.1007/978-981-13-7538-5_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-7537-8
Online ISBN: 978-981-13-7538-5
eBook Packages: MedicineMedicine (R0)